Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPHA.1-PROTEINASE INHIBITOR HUMAN vs ALTEPLASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPHA.1-PROTEINASE INHIBITOR HUMAN vs ALTEPLASE: Safety Overview

Metric ALPHA.1-PROTEINASE INHIBITOR HUMAN ALTEPLASE
Total FAERS Reports 7,110 12,687
Deaths Reported 635 2,540
Death Rate 8.9% 20.0%
Hospitalizations 2,049 2,083
Average Patient Age 61.3 yrs 62.5 yrs
% Female Patients 58.2% 42.4%
Manufacturer Takeda Pharmaceuticals America, Inc. Genentech, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription